| Home > Publications Database > Safety of lenadogene nolparvovec gene therapy over 5 years in 189 patients with Leber hereditary optic neuropathy. > Access to Fulltext |
DZNE-2023-00034
|
|||||||
| version 1 |
| ||||||
DZNE-2023-00034_SUPP
|
|||||||||||||
| version 1 |
| ||||||||||||